Myth-buster
A meta-analysis of small vitamin D trials found a 0.88 odds ratio for ICU admission — but a subtle statistical signal shows those results may be a mirage, while larger trials found no benefit.
This analysis suggests that the belief vitamin D prevents severe COVID-19 is likely built on small, flattering studies that got published because they were positive — the bigger, more reliable trials saw nothing.
Researchers pooled data from small randomized trials on vitamin D and COVID-19 severity and found no statistically significant reduction in ICU admissions. However, when they compared tiny studies (106 patients) to larger ones (up to 548), the smaller studies appeared to exaggerate benefits — a pattern that strongly hints at publication bias, where flashy positive results get published while null results sit in a drawer.
Where this fits in the evidence
This is among the first studies we've indexed on Vitamin D for Reduced Intensive Care Unit Admission — treat it as an early signal until more research accumulates.
The study
- Meta-Analysis
- n = 548
- 2025-01-14
- PloS one
This is a plain-language summary of a research finding, not medical advice. Pillser surfaces research signals to help you decide what's worth investigating — always consult a qualified professional before changing what you take.